2-METHYL-2-(3-METHYL-4-NITRO-1H-PYRAZOL-1-YL)PROPANAMIDE, 95.0%, 100mg

Naproxen ethyl ester, 98.0%, 25g

N,N-dimethylacetamide, min. 99%, for synthesis, 2.5 l, glass packaging

NETUPITANT, 95%, 250mg

5,7-Dichloro-3-ethylpyrazolo[1,5-a]pyrimidine, 95.0%, 100mg

6-fluoro-1-methyl-1H-indole-3-carbaldehyde, 95.0%, 1g

6-Chloro-4-formylpyridine-3-carboxylic acid, 95+%, 1g

1-(4-Chlorophenyl)-2-methoxyethan-1-one, 95+%, 1g

2-(2-methyl-1H-imidazol-1-yl)ethanol, 95.0%, 10g

6-(2H-1,2,3-Triazol-2-yl)-5-(trifluoromethyl)pyridin-3-amine, 97%, 5g

Bis((S)-4-phenyl-4,5-dihydrooxazol-2-yl)methane, 95.0%, 250mg

3-(3-methylphenyl)-1-propanamine, 95.0%, 5g

5-(Aminomethyl)-5-(4-fluorophenyl)imidazolidine-2,4-dione hydrochloride, 95%, 1g